CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 57 enrolled
Drug / intervention
Human papillomavirus testing +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04587050
NCT04587050N/ACompleted
CompareCT.gov

Screening for Human Papillomavirus and Cervical Cancer in Young Women With Perinatally Acquired HIV

Imperial College London·observational·Posted Oct 14, 2020·Updated Dec 10, 2024

In Brief

An observational study evaluating Human papillomavirus testing, Cervical cytology, and 1 other intervention for HIV Infections and 2 related conditions. Completed, enrolled 57 participants across 1 site.

Detailed Summary

This is a cross-sectional, observational study of high-risk HPV status, cervical cytology and HPV vaccine uptake and response in young women with perinatally acquired HIV.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections, Human Papillomavirus Infection, Cervical Cancer
CountriesUnited Kingdom
CollaboratorsPublic Health England

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 14, 2020
Enrollment StartJul 19, 2021
Primary CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.7 years ago

Interventions

Human papillomavirus testingother

HPV test from cervical sample using Cepheid GeneXpert HPV

Cervical cytologyother

Cervical cytology

HPV serologyother

HPV type specific serology (16/18) using ELISA from serum samples